Tuesday, June 23, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 655 of 1,261
  1. US 9540471

    Nitric oxide-releasing diazeniumdiolated polyvinylpyrrolidone-based polymers, and compositions, medical devices, and uses thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jan 10, 2017 · Expires Jan 5, 2037

    granted
  2. US 9539321

    HMGB1-derived peptides enhance immune response to antigens

    The Regents of the University of California · Granted Jan 10, 2017 · Expires Jan 5, 2037

    granted
  3. US 9539300

    Modulating disease through genetic engineering of plants

    The Regents of the University of California · Granted Jan 10, 2017 · Expires Jan 5, 2037

    granted
  4. US 9539283

    Citrate-rich calcium-magnesium supplement and uses thereof

    The Board of Regents of the University of Texas System · Granted Jan 10, 2017 · Expires Jan 5, 2037

    granted
  5. US 9539256

    Modulators of exchange proteins directly activated by cAMP (EPACS)

    The Board of Regents of the University of Texas System · Granted Jan 10, 2017 · Expires Jan 5, 2037

    granted
  6. US 9539207

    Method for delivering pramlintide into a lumen of the intestinal tract using a swallowable drug delivery

    Rani Therapeutics, LLC · Granted Jan 10, 2017 · Expires Jan 5, 2037

    granted
  7. WO 2017004561

    ASSOCIATIONS DE PEPTIDES ET LEURS UTILISATIONS DANS LE TRAITEMENT DE L'ALLERGIE AUX GRAMINÉES

    ALK-ABELLÓ AS [DK] · Granted Jan 5, 2017 · Expires Dec 31, 2036

    granted
  8. US 9533990

    Inhibitors of secretion of hepatitis B virus antigens

    ARBUTUS BIOPHARMA CORPORATION · Granted Jan 3, 2017 · Expires Dec 29, 2036

    granted
  9. US 9533039

    Methods of treating systemic lupus erythematosus (SLE) using anti-CD48 antibodies

    REGENERON PHARMACEUTICALS, INC. · Granted Jan 3, 2017 · Expires Dec 29, 2036

    granted
  10. US 9533025

    Method for treating chemotherapy-induced male infertility

    The Board of Regents of the University of Texas System · Granted Jan 3, 2017 · Expires Dec 29, 2036

    granted
  11. US 9533031

    Yeast-MUC1 immunotherapeutic compositions and uses thereof

    The United States of America as Represented by the Secretary, Dept. of Health and Human Services · Granted Jan 3, 2017 · Expires Dec 29, 2036

    granted
  12. US 9532994

    Agents and methods for enhancing bone formation by oxysterols in combination with bone morphogenic proteins

    The Regents of the University of California · Granted Jan 3, 2017 · Expires Dec 29, 2036

    granted
  13. US 9534044

    Alpha-synuclein antibodies and uses thereof

    UNITED ARAB EMIRATES UNIVERSITY · Granted Jan 3, 2017 · Expires Dec 29, 2036

    granted
  14. US 9534277

    Method for purification of 225AC from irradiated 226RA-targets

    Actinium Phamaceuticals, Inc. · Granted Jan 3, 2017 · Expires Dec 29, 2036

    granted
  15. US 9534220

    Antisense antibacterial method and compound

    Sarepta Therapeutics, Inc. · Granted Jan 3, 2017 · Expires Dec 29, 2036

    granted
  16. US 9535076

    Methods and compositions for eliciting an amyloid-selective immune response

    The Regents of the University of California · Granted Jan 3, 2017 · Expires Dec 29, 2036

    granted
  17. US 9534033

    Targeted interferons demonstrating potent apoptotic and anti-tumor activities

    The Regents of the University of California · Granted Jan 3, 2017 · Expires Dec 29, 2036

    granted
  18. US 9534041

    Monoclonal antibodies that neutralize a norovirus

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jan 3, 2017 · Expires Dec 29, 2036

    granted
  19. US 9534008

    Small molecule compounds that control plant- and insect-pathogenic nematodes

    The United States of America, as represented by the Secretary of Agriculture · Granted Jan 3, 2017 · Expires Dec 29, 2036

    granted
  20. US 9534007

    Methods and compositions for treatment of cyanide and hydrogen sulfide toxicity

    United States of America as represented by the Secretary of the Air Force · Granted Jan 3, 2017 · Expires Dec 29, 2036

    granted
  21. US 9533987

    Heterocyclic derivates

    KalVista Pharmaceuticals Limited · Granted Jan 3, 2017 · Expires Dec 29, 2036

    granted
  22. US 9533981

    Pyridine derivatives

    Asana BioSciences, LLC · Granted Jan 3, 2017 · Expires Dec 29, 2036

    granted
  23. US 9533045

    Photothermal therapy using magnetic nanoparticles

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Jan 3, 2017 · Expires Dec 29, 2036

    granted
  24. US 9533947

    Benzamide compounds and related methods of use

    Northwestern University · Granted Jan 3, 2017 · Expires Dec 29, 2036

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.